Corrigendum to "Stress, NPY and vascular remodeling: Implications for stress-related diseases" [Peptides 28 (2007) 435-440] (DOI:10.1016/j.peptides.2006.08.035);Stress, NPY and vascular remodeling: Implications for stress-related diseases

Peptides

Volumn 28, Issue 2, 2007, Pages 435-440

  Kuo, Lydia E ^a   Zukowska, Zofia ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Atherosclerosis; Norepinephrine; NPY; NPY receptor antagonists; Obesity; Restenosis; Stress

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; LIPID; MITOGENIC AGENT; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR ANTAGONIST; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ANGIOGENESIS; ANGIOPLASTY; ARTERY INJURY; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; HEART VENTRICLE HYPERTROPHY; HUMAN; INTIMA; ISCHEMIA; MACROPHAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RESTENOSIS; RETINOPATHY; REVASCULARIZATION; REVIEW; STRESS; SYMPATHETIC NERVE; SYSTEMATIC REVIEW; THROMBUS; VASOCONSTRICTION; WOUND HEALING;

ANGINA;

EID: 33846625583     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.02.005     Document Type: Erratum

References (43)

1. Bedoui S., Kawamura N., Straub R.H., Pabst R., Yamamura T., and von Horsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol 134 (2003) 1-11
2. Brakenhielm E., Cao R., Gao B., Angelin B., Cannon B., Parini P., et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 94 (2004) 1579-1588
3. Chen S.H., and Han Q.D. Increase of release of neuropeptide Y in vitro from platelets of spontaneously hypertensive rats. Zhongguo Yao Li Xue Bao 16 (1995) 149-152
4. Clarke J.G., Davies G.J., Kerwin R., Hackett D., Larkin S., Dawbarn D., et al. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1 (1987) 1057-1059
5. Dumont Y., Martel J.C., Fournier A., St-Pierre S., and Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 38 (1992) 125-167
6. Ekstrand A.J., Cao R., Bjorndahl M., Nystrom S., Jonsson-Rylander A.C., Hassani H., et al. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA 100 (2003) 6033-6038
7. Ericsson A., Hemsen A., Lundberg J.M., and Persson H. Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. Exp Cell Res 192 (1991) 604-611
8. Esler M., Alvarenga M., Pier C., Richards J., El-Osta A., Barton D., et al. The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J Psychopharmacol 20 (2006) 60-66
9. Ghersi G., Dong H., Goldstein L.A., Yeh Y., Hakkinen L., Larjava H.S., et al. Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex. J Biol Chem 277 (2002) 29231-29241
10. Goldstein D.S. Stress-induced activation of the sympathetic nervous system. Baillieres Clin Endocrinol Metab 1 (1987) 253-278
11. Hagstrom-Toft E., Arner P., Wahrenberg H., Wennlund A., Ungerstedt U., and Bolinder J. Adrenergic regulation of human adipose tissue metabolism in situ during mental stress. J Clin Endocrinol Metab 76 (1993) 392-398
12. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 38 (2004) 213-224
13. Kallio J., Pesonen U., Kaipio K., Karvonen M.K., Jaakkola U., Heinonen O.J., et al. Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB J 15 (2001) 1242-1244
14. Kalra S.P., and Kalra P.S. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 38 (2004) 201-211
15. Karvonen M.K., Valkonen V.P., Lakka T.A., Salonen R., Koulu M., Pesonen U., et al. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis 159 (2001) 145-151
16. Kitlinska J., Abe K., Kuo L., Pons J., Yu M., Li L., et al. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res 65 (2005) 1719-1728
17. Kitlinska J., Lee E.W., Li L., Pons J., Estes L., and Zukowska Z. Dual role of dipeptidyl peptidase IV (DPP IV) in angiogenesis and vascular remodeling. Adv Exp Med Biol 524 (2003) 215-222
18. Kitlinska J., Lee E.W., Movafagh S., Pons J., Zukowska Z., and Neuropeptide. Y-induced angiogenesis in aging. Peptides 23 (2002) 71-77
19. Koulu M., Movafagh S., Tuohimaa J., Jaakkola U., Kallio J., Pesonen U., et al. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann Med 36 (2004) 232-240
20. Lappalainen J., Kranzler H.R., Malison R., Price L.H., Van Dyck C., Rosenheck R.A., et al. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch Gen Psychiatry 59 (2002) 825-831
21. Lee E.W., Grant D.S., Movafagh S., and Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 24 (2003) 99-106
22. Lee E.W., Michalkiewicz M., Kitlinska J., Kalezic I., Switalska H., Yoo P., et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111 (2003) 1853-1862
23. Lewandowski J., Pruszczyk P., Wocial B., Ignatowska-Switalska H., Romejko-Wolniewicz E., Madej-Firek A., et al. Sex hormone modulation of neuropeptide Y and cardiovascular responses to stress in humans. In: McCarty GA R., Sabban E., and Kvetnansky R. (Eds). Stress: molecular genetic and neurobiological advances (1996), Gordon and Breach Science Publishers S.A., New York, NY 569-578
24. Li L., Jonsson-Rylander A.C., Abe K., and Zukowska Z. Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors. Arterioscler Thromb Vasc Biol 25 (2005) 2075-2080
25. Li L., Lee E.W., Ji H., Zukowska Z., and Neuropeptide. Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler Thromb Vasc Biol 23 (2003) 1204-1210
26. Ludwig R., Lucius R., and Mentlein R. A radioactive assay for the degradation of neuropeptide Y. Biochimie 77 (1995) 739-743
27. Movafagh S., Hobson J.P., Zukowska Z., and Neuropeptide Y. (NPY) induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J (2006)
28. Myers A.K., Torres Duarte A.P., and Zukowska-Grojec Z. Immunoreactive neuropeptide Y (NPY) in plasma and platelets of rat and mouse strains and human volunteers. Regul Pept 47 (1993) 239-245
29. Ogawa T., Kitamura K., Kangawa K., Matsuo H., and Eto T. Platelet neuropeptide Y in spontaneously hypertensive rats. J Hypertens 10 (1992) 765-771
30. Palmiter R.D., Erickson J.C., Hollopeter G., Baraban S.C., and Schwartz M.W. Life without neuropeptide Y. Recent Prog Horm Res 53 (1998) 163-199
31. Papademetriou V., Gottdiener J.S., Kop W.J., Howell R.H., and Krantz D.S. Transient coronary occlusion with mental stress. Am Heart J 132 (1996) 1299-1301
32. Petraglia F., Coukos G., Battaglia C., Bartolotti A., Volpe A., Nappi C., et al. Plasma and amniotic fluid immunoreactive neuropeptide-Y level changes during pregnancy, labor, and at parturition. J Clin Endocrinol Metab 69 (1989) 324-328
33. Pons J., Kitlinska J., Ji H., Lee E.W., and Zukowska Z. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can J Physiol Pharmacol 81 (2003) 177-185
34. Rupnick M.A., Panigrahy D., Zhang C.Y., Dallabrida S.M., Lowell B.B., Langer R., et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99 (2002) 10730-10735
35. Saitongdee P., Milner P., Loesch A., Knight G., and Burnstock G. Electron-immunocytochemical studies of perivascular nerves of mesenteric and renal arteries of golden hamsters during and after arousal from hibernation. J Anat 195 Pt 1 (1999) 121-130
36. Wahlestedt C., Hakanson R., Vaz C.A., and Zukowska-Grojec Z. Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am J Physiol 258 (1990) R736-R742
37. Westfall T.C., Yang C.L., and Curfman-Falvey M. Neuropeptide-Y-ATP interactions at the vascular sympathetic neuroeffector junction. J Cardiovasc Pharmacol 26 (1995) 682-687
38. Wheway J., Mackay C.R., Newton R.A., Sainsbury A., Boey D., Herzog H., et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 202 (2005) 1527-1538
39. Wiedeman P.E., and Trevillyan J.M. Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes. Curr Opin Invest Drugs 4 (2003) 412-420
40. Zukowska-Grojec Z., Dayao E.K., Karwatowska-Prokopczuk E., Hauser G.J., and Doods H.N. Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. Am J Physiol 270 (1996) H796-H800
41. Zukowska-Grojec Z., Golczynska M., Lewandowski J., Pruszczyk P., Switalska H., Hiremagalur B., et al. Neuropeptide Y: a major regulator of cardiovascular responses to stress. In: McCarty GA R., Sabban E., and Kvetnansky R. (Eds). Stress: molecular genetic and neurobiological advances (1996), Gordon and Breach Science Publishers S.A, New York, NY 513-529
42. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H., et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83 (1998) 187-195
43. Zukowska-Grojec Z., and Vaz A.C. Role of neuropeptide Y (NPY) in cardiovascular responses to stress. Synapse 2 (1988) 293-298